Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Microvast Holdings, Inc. (MVST) SEC Filings & Earnings Calls

EquiReason read 13 Microvast Holdings, Inc. SEC filings in the last 12 months. Latest: DEF 14A on 2026-10-09 — Proxy statement for annual meeting; no material event disclosed..

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

MVSTMicrovast Holdings, Inc.Follow MVST — free
Auto Parts · Consumer Cyclical
—
Price chart with a free account
Market cap
191.7M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
16 Nov, in 23 days

Every filing, read

last 12 months · SEC

What happened, the numbers inside, guidance and risks. The original is one click away.

9 Oct 2026DEF 14AProxy statement for annual meeting; no material event disclosed.open

Figures in the filing · each found in the filing text

Revenue · FY2025$428M
Operating Profit Margin · FY20251.6%
Accounts Receivable Collection Days · FY2025156
Net Income · FY2025$-29M
Revenue · FY2024$380M
Net Income · FY2024$-195M
Revenue · FY2023$307M
Net Income · FY2023$-106M

Risks flagged

Operating margin pressure

“Operating Profit Margin 1.63% vs target 5.5%”

Working capital strain

“AR Collection 156 days vs target 85 days”

CEO control risk

“Yang Wu beneficial ownership 35.8%”
Read the original on SEC EDGAR ↗
31 Aug 20268-K · 3.01Microvast received Nasdaq notice for non-compliance with minimum bid price rule; has 180 days to cure. Stock continues trading with non-compliance indicator.open

Risks flagged

Potential delisting if bid price not cured within 180 days; could lead to loss of investor confidence, reduced liquidity, and financing challenges.

“In the event the Company does not evidence compliance with the minimum closing bid price requirement during the 180-day grace period... it is expected that Nasdaq would notify the Company that the shares of Common Stock are subject to delisting.” · word for word
Read the original on SEC EDGAR ↗
11 Aug 20268-K · 2.02Revenue $87M (-4% y/y); Gross margin 29.5; Net loss $-12Mearningsopen

Figures in the filing · each found in the filing text

Revenue · Q2-2026$87M-5% y/y
Gross margin · Q2-202629.5%
Net loss · Q2-2026$-12M
Non-GAAP adjusted EBITDA · Q2-2026$4M
Capital expenditures · Q2-2026$11M
Cash, cash equivalents and restricted cash · Q2-2026$143M

Risks flagged

Revenue decline and margin compression due to raw material costs, tariff impacts, and lower utilization.

“Revenues... decreasing by 4.5%... Gross margin decreased to 29.5% from 34.7%... due to higher raw material prices, and lower production utilization.”

Geopolitical and regulatory risks in Indian and Korean markets.

“evolving regulatory and geopolitical dynamics, including in the Indian and Korean markets, demand shift towards lower-cost products in India.” · word for word

Cash burn from operations and capex; cash decreased from $169.2M to $143.1M.

“Cash... of $143.1 million... compared to $169.2 million as of December 31, 2025.”
Read the original on SEC EDGAR ↗
10 Aug 202610-QMicrovast reported a significant revenue decline, gross margin compression, negative operating cash flow, and disclosed substantial doubt about its ability to continue as a going concern.earningsopen

Figures in the filing · each found in the filing text

Gross profit margin · H1-202630.4%
Net income (loss) · H1-2026$36M
Operating cash flow · H1-2026$-33M

Guidance

Revenue decline of 28.8% YoY for H1 2026; gross margin down from 36.0% to 30.4%

Company's performance deteriorated significantly, with substantial doubt about going concern, indicating a de facto guidance cut.

Risks flagged

Going concern risk

“Based on our revised business plan, our projected cash flow may not be sufficient to fund operations and meet debt obligations over the next twelve months. Additionally, recent equity market conditions and business performance have rendered our equity funding unfavorable as a primary liquidity mechanism. These conditions and events raise substantial doubt ab” · word for word

Near-term debt maturity risk

“As of June 30, 2026, $104.2 million of our $118.6 million of borrowings were due within the next 12 months, and the $41.7 million of bonds payable issued by our Chinese subsidiary to a Chinese governmental entity is repayable on or before January 31, 2027.” · word for word

Customer concentration risk

“Our revenues for the three and six months ended June 30, 2026 were materially concentrated with a small number of customers.” · word for word

Tariff and trade policy risk

“on July 23, 2026, the current presidential administration of the United States announced the imposition of 10% - 12.5% tariffs on imports from sixty economies under Section 301 of the Trade Act of 1974.” · word for word

Nasdaq delisting risk

“Beginning on July 13, 2026, the closing bid price of our common stock has been below $1.00 per share.” · word for word
Read the original on SEC EDGAR ↗
7 Aug 20268-K · 5.02Reported the departure of a director or principal officer (CEO/CFO change); filed financial statements and exhibits with this reportSEC ↗
28 May 20268-K · 5.02, 8.01Convertible loan principal converted $25Mopen

Figures in the filing · each found in the filing text

Convertible loan principal converted$25M

Risks flagged

Significant dilution from CEO's conversion of $25M convertible loan; CAO departure adds management instability.

“$25M loan converted to shares; CAO departed.”
Read the original on SEC EDGAR ↗
11 May 20268-K · 2.02Revenue $61M (-48% y/y); Gross margin 31.6; Net profit $48M (-22% y/y)earningsopen

Figures in the filing · each found in the filing text

Revenue · Q1-2026$61M-48% y/y
Gross margin · Q1-202631.6%
Net profit · Q1-2026$48M-22% y/y
Non-GAAP adjusted net loss · Q1-2026$-15M
Non-GAAP adjusted EBITDA · Q1-2026$-6M
Capital expenditures · Q1-2026$4M-36% y/y
Cash, cash equivalents and restricted cash · Q1-2026$174M+42% y/y

Risks flagged

Severe revenue decline due to geopolitical and regulatory headwinds in key markets

“Revenue down 48% YoY; impact from India/Korea markets, demand shift to lower-cost products, OEM delays.”

Negative non-GAAP adjusted EBITDA and net loss

“Non-GAAP adjusted EBITDA -$5.5M; non-GAAP adjusted net loss -$14.6M.”

Tariff and geopolitical uncertainty

“While we continue to navigate evolving tariff structures and shifting geopolitical dynamics...” · word for word
Read the original on SEC EDGAR ↗
11 May 202610-QRevenue $61M (-48% y/y); Gross Profit Margin 31.6; Net Income $48M (-22% y/y)open

Figures in the filing · each found in the filing text

Revenue · Q1-2026$61M-48% y/y
Gross Profit Margin · Q1-202631.6%
Net Income · Q1-2026$48M-22% y/y
Operating Cash Flow · Q1-2026$-23M
Free Cash Flow · Q1-2026$-26M
Backlog · 2026-03-31$169M
Sales Volume · Q1-2026$273.90-49% y/y

Risks flagged

Going Concern Risk

“These conditions and events raise substantial doubt about our ability to continue as a going concern.” · word for word

Customer Concentration Risk

“Customer A 52 % Customer B 18 %”

Geopolitical/Tariff Risk

“The implementation of new tariff frameworks has increased the cost of goods sold.” · word for word
Read the original on SEC EDGAR ↗
16 Mar 20268-K · 2.02Revenue $428M (+13% y/y); Net loss $-29M; Non-GAAP adjusted net profit $13M; Guidance: Expects continued revenue growth in 2026 but no specific numbers; targeting strong gross marginearningsopen

Figures in the filing · each found in the filing text

Revenue · FY2025$428M+13% y/y
Net loss · FY2025$-29M
Non-GAAP adjusted net profit · FY2025$13M
Non-GAAP adjusted EBITDA · FY2025$45M
Gross margin · FY202528.6%
Capital expenditures · FY2025$39M-22% y/y
Cash, cash equivalents, restricted cash · FY2025$169M+54% y/y
Revenue · Q4-2025$96M-15% y/y
Net profit · Q4-2025$17M
Non-GAAP adjusted net loss · Q4-2025$-35M

Guidance

Expects continued revenue growth in 2026 but no specific numbers; targeting strong gross margin

Microvast expects continued revenue growth in 2026 but faces headwinds from tariffs, regulatory shifts, and customer delays. No specific guidance provided. Targeting strong gross margin but Q4 margin was severely impacted by inventory impairment.

Risks flagged

Regulatory shifts in South Korea and customer platform delays in EMEA caused revenue miss and Q4 decline.

“Revenue of $96.4 million, compared to $113.4 million in Q4 2024, a decrease of 15.0% as a result of regulatory shifts in South Korea and delays in customer platform ramp up in EMEA.” · word for word

Inventory impairment of $32.5M related to specialized ESS components significantly impacted gross margin.

“Gross margin decreased to 28.6%, compared to 31.5% in 2024, this change was primarily attributable to a $32.5 million inventory impairment charge related to specialized ESS components, which negatively impacted our gross margin by 7.6 percentage points.” · word for word

Evolving tariff structures and geopolitical events create uncertainty for 2026 outlook.

“While we are navigating evolving tariff structures and shifting regulatory and geopolitical events, we expect continued revenue growth in 2026.” · word for word
Read the original on SEC EDGAR ↗
16 Mar 202610-KRevenue $428M (+13% y/y); Gross Profit $122M (+2% y/y); Gross Margin 28.6; Guidance: backlog $196.1M; management plans to alleviate going concernopen

Figures in the filing · each found in the filing text

Revenue · FY2025$428M+13% y/y
Gross Profit · FY2025$122M+2% y/y
Gross Margin · FY202528.6%
Net Income · FY2025$-29M+85% y/y
Operating Cash Flow · FY2025$76M
Backlog · 2025-12-31$196M
China Revenue · China · FY2025$139M+9% y/y
Europe Revenue · Europe · FY2025$212M+13% y/y
U.S. Revenue · U.S. · FY2025$39M+173% y/y
Sales Volume (MWh) · FY20251,879.5+17% y/y

Guidance

backlog $196.1M; management plans to alleviate going concern

No explicit revenue guidance; management expresses confidence in alleviating going concern through operating cash flows, refinancing, and equity sales.

Risks flagged

Going Concern Risk

“Based on our current business plan, we projected that existing cash and assets held for sale would not be sufficient to fund operations through the next twelve months.” · word for word

Customer Concentration

“For the year ended December 31, 2025, the two largest customers accounted for 22% and 17% of our net revenues respectively.” · word for word

U.S. Facility Funding Risk

“Construction and equipment installation for our U.S. facility was suspended in the second quarter of 2024 due to funding constraints.” · word for word

Regulatory and Tariff Risk

“These incentives are subject to evolving geopolitical dynamics, including Foreign Entity of Concern restrictions and domestic content requirements.” · word for word
Read the original on SEC EDGAR ↗
9 Jan 20268-K · 5.02Reported the departure of a director or principal officer (CEO/CFO change); filed financial statements and exhibits with this reportopen

Risks flagged

No material risk; routine executive appointment.

“No disagreements or family relationships disclosed.”
Read the original on SEC EDGAR ↗
10 Nov 202510-QMicrovast reported strong Q3 2025 results with revenue up 21.6% YoY, gross margin expansion to 37.6%, and positive operating profit for the nine-month period, indicating improved financial health.earningsopen

Figures in the filing · each found in the filing text

Gross Profit Margin · Q3-202537.6%
Backlog · 2025-09-30$238M
Sales Volume (MWh) · Q3-2025$501.70+16% y/y
Operating Profit · 9M-2025$48M
Operating Cash Flow · 9M-2025$60M
Cash and Cash Equivalents · 2025-09-30$59M
Net Income (Loss) Attributable to Microvast Holdings, Inc. · Q3-2025$-1M

Guidance

Backlog of $237.7M expected to be fulfilled in 2025 and 2026; positive operating cash flow expected

Management expresses confidence in continued positive cash flow and backlog fulfillment, but does not provide explicit quantitative guidance.

Risks flagged

Going Concern Uncertainty

“Considering operating requirements under our current business plan, we are projecting that the existing cash and assets available for sale and equity securities will not be sufficient to fund our operations through the next twelve months.” · word for word

Funding Constraint for Clarksville Facility

“Additional financing is needed to resume progress for our Clarksville facility, and further progress is still contingent on having full access to funding to complete the remaining project work.” · word for word

Customer Concentration

“We have historically derived a portion of our revenue in a given reporting period from a limited number of key customers, which vary from period to period.” · word for word

Trade Policy and Tariff Exposure

“Changes in tariff policy in particular, whether threatened or implemented, may raise costs for consumers which could lead to softened consumer demand.” · word for word

Raw Material Price Volatility

“Our manufacturing costs are affected by fluctuations in the price of raw materials. If raw material prices increase, we will have to offset these higher costs either through price increases to our customers or through productivity improvements.” · word for word
Read the original on SEC EDGAR ↗
10 Nov 20258-K · 2.02Revenue $123M (+22% y/y); Gross margin 37.6; Adjusted EBITDA $22M; Guidance: Revenue $450-475M; gross margin 32-35%earningsopen

Figures in the filing · each found in the filing text

Revenue · Q3-2025$123M+22% y/y
Gross margin · Q3-202537.6%
Adjusted EBITDA · Q3-2025$22M
Net loss · Q3-2025$-2M
Capital expenditures · Q3-2025$17M
Cash and cash equivalents · Q3-2025$143M

Guidance

Revenue $450-475M; gross margin 32-35%

Revenue guidance maintained; gross margin outlook raised; capacity expansion underway.

Risks flagged

Net loss reported despite revenue growth; GAAP profitability not yet achieved.

“Net loss of $1.5 million in Q3 2025 vs net profit of $13.2 million in Q3 2024”
Read the original on SEC EDGAR ↗

Microvast Holdings, Inc. — questions

What did Microvast Holdings, Inc. file recently?
13 SEC filings in the last 12 months. Latest: DEF 14A on 2026-10-09 — Proxy statement for annual meeting; no material event disclosed.

Every figure on this page comes from Microvast Holdings, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.